How Much Does Jatenzo Cost in West Virginia in 2026?

Cash-Pay Price at West Virginia Pharmacies

The average cash-pay price for Jatenzo across West Virginia retail pharmacies in 2026 sits at approximately $900 per month. That figure aligns closely with Tolmar's manufacturer list price, which has remained steady since the drug's FDA approval in March 2019 for the treatment of hypogonadism in adult males.

Pricing can shift between pharmacies. Chain pharmacies in Morgantown or Charleston may price Jatenzo differently than independent pharmacies in smaller communities across the state. The drug does not yet have an FDA-approved generic equivalent, which limits competitive pricing pressure. Oral testosterone undecanoate (the active compound in Jatenzo) received its first U.S. approval with this product after decades of availability in other countries.

A 2020 pharmacokinetic and efficacy trial by Swerdloff et al. (J Clin Endocrinol Metab, 2020) confirmed that Jatenzo restored testosterone levels to the eugonadal range (300-1 to 000 ng/dL) in 87% of treated men at the 158 mg twice-daily dose. That trial enrolled 166 hypogonadal men and demonstrated a mean serum testosterone (C_avg) of 489 ng/dL over 365 days. The clinical profile matters for cost discussions because it establishes why a prescriber might favor this oral formulation over cheaper injectable alternatives.

Without insurance, most West Virginia patients should expect to pay between $850 and $950 per month depending on the dispensing pharmacy and any negotiated pricing agreements. Coupon aggregator sites occasionally show slightly lower prices, but these reflect specific pharmacy partnerships rather than universal WV pricing.

West Virginia Medicaid Does Not Cover Jatenzo

West Virginia Medicaid does not include Jatenzo on its preferred drug list as of 2026. Patients enrolled in Medicaid managed care plans (such as those administered through The Health Plan, Aetna Better Health of West Virginia, or UniCare) will find the same exclusion. This coverage gap is not unique to West Virginia. Many state Medicaid programs exclude branded oral testosterone formulations due to the availability of lower-cost injectable testosterone cypionate, which typically costs $30 to $75 per month.

For Medicaid-enrolled men diagnosed with hypogonadism, the standard covered alternative is injectable testosterone cypionate (typically 100-200 mg intramuscularly every 1-2 weeks) or topical testosterone gels. These remain the Endocrine Society guideline-recommended first-line therapies for testosterone replacement. The 2018 Endocrine Society Clinical Practice Guideline states: "We recommend testosterone therapy for men with symptomatic testosterone deficiency to induce and maintain secondary sex characteristics and to improve sexual function, sense of well-being, and bone mineral density."

A prior authorization request is theoretically possible if a patient has documented contraindications or treatment failures with injectable and topical formulations. Prescribers would need to demonstrate medical necessity. In practice, approvals for branded oral testosterone through West Virginia Medicaid are rare.

Commercial Insurance Coverage Across WV Plans

Coverage for Jatenzo among commercial insurers in West Virginia varies significantly by carrier and plan tier. Some plans administered by Highmark Blue Cross Blue Shield, The Health Plan, or national carriers like United Healthcare and Cigna may include Jatenzo on a specialty or non-preferred brand tier. Others exclude it entirely.

Patients can expect one of three scenarios. First, the plan covers Jatenzo on a non-preferred brand tier with a copay between $75 and $200 per month. Second, the plan covers Jatenzo only after prior authorization, step therapy (requiring documented failure of injectable or topical testosterone first), or both. Third, the plan excludes Jatenzo outright, leaving the patient responsible for the full cash price.

The Endocrine Society's 2018 guideline identifies injectable testosterone as first-line therapy based on efficacy, safety, and cost. Most formulary committees use this recommendation to justify step-therapy requirements before approving branded oral alternatives. A 2020 analysis published in the Journal of the Endocrine Society examined testosterone formulation costs and found that monthly treatment costs for oral testosterone undecanoate were 10 to 30 times higher than generic injectable testosterone cypionate.

Before filling a prescription, call the number on the back of your insurance card and ask three specific questions: Is Jatenzo on my formulary? What tier is it on? Does it require prior authorization or step therapy? These answers will determine your actual out-of-pocket cost.

The Tolmar Savings Card and How It Works in WV

Tolmar, the manufacturer of Jatenzo, offers a copay savings card that can reduce out-of-pocket costs substantially for commercially insured patients. The card is not available to patients insured through government programs (Medicaid, Medicare, Tricare, or VA). Eligible patients with commercial insurance may pay as little as $0 per month, depending on the terms of the current program.

Here is how the process works in West Virginia. The patient or prescriber enrolls through the Tolmar website or by calling the support line. A savings card number is generated. The patient presents this card alongside their insurance card at their WV pharmacy. The pharmacy processes the claim through insurance first, then applies the savings card to the remaining copay or coinsurance. The savings card typically covers up to a set maximum per month or per year.

Terms and maximum benefit amounts change periodically. Patients should verify current program details directly with Tolmar before assuming specific dollar amounts. The card is usable at any retail pharmacy in West Virginia that stocks Jatenzo, including chains like CVS, Walgreens, Rite Aid, and Fruth Pharmacy (a WV-based chain with locations throughout the state).

One important limitation: if the patient's insurance plan excludes Jatenzo entirely (meaning no insurance claim processes), many manufacturer copay cards will not activate. The card typically requires a primary insurance adjudication before applying the discount. Patients whose plans exclude Jatenzo may need to explore patient assistance programs or compounded alternatives instead.

Compounded Oral Testosterone Undecanoate in West Virginia

Compounded oral testosterone undecanoate is available in West Virginia through licensed 503A compounding pharmacies. A 503A pharmacy prepares compounded medications based on individual patient prescriptions, as permitted under Section 503A of the Federal Food, Drug, and Cosmetic Act. The legality of compounding testosterone formulations in West Virginia follows both federal 503A provisions and West Virginia Board of Pharmacy regulations.

The cost advantage can be significant. While branded Jatenzo runs $900 per month, compounded oral testosterone undecanoate from a 503A pharmacy can cost substantially less. Pricing depends on the specific compounding pharmacy, dose, and quantity, but patients report costs ranging from $50 to $200 per month for compounded oral formulations.

There are clinical considerations to weigh. Compounded testosterone products are not FDA-approved, which means they have not undergone the same rigorous bioequivalence and stability testing as Jatenzo. The FDA has issued guidance noting that compounded drugs do not carry the same assurances of safety, efficacy, and quality as FDA-approved products. Dr. Shalender Bhasin, a professor of medicine at Harvard Medical School and lead author of several Endocrine Society testosterone guidelines, has stated: "Compounded testosterone products vary in their pharmacokinetic profiles, and clinicians should monitor serum testosterone levels more frequently when switching patients from an FDA-approved product to a compounded formulation."

A prescriber in West Virginia can write a prescription for compounded oral testosterone undecanoate and direct the patient to a licensed 503A pharmacy within the state or to an out-of-state 503A pharmacy that ships to West Virginia. The prescription must be patient-specific. Patients considering this option should discuss monitoring protocols with their prescriber, including checking serum testosterone trough levels 4 to 6 weeks after starting the compounded product.

Telehealth Access to Jatenzo in West Virginia

Telehealth prescribing of Jatenzo is legal in West Virginia. The state's telehealth parity laws, reinforced during and after the COVID-19 public health emergency, allow licensed prescribers to evaluate patients via video or audio visits and prescribe Schedule III controlled substances (which includes testosterone) when clinically appropriate.

For West Virginia residents in rural counties where endocrinologists or urologists are scarce, telehealth removes a major access barrier. A patient in McDowell County, for example, can consult with a licensed prescriber without driving 2+ hours to the nearest specialist. The prescriber conducts a clinical evaluation, reviews laboratory results (total testosterone drawn on two separate mornings, per Endocrine Society guidelines), and issues the prescription electronically to the patient's preferred West Virginia pharmacy.

Several national telehealth platforms now operate in West Virginia and offer testosterone replacement therapy evaluations. Patients should confirm that the platform's prescribers hold active West Virginia medical licenses and that the platform can prescribe Jatenzo specifically (some telehealth TRT clinics only prescribe injectable testosterone cypionate or topical gels).

The combination of telehealth access plus the Tolmar savings card can make Jatenzo financially accessible for some commercially insured West Virginia patients who might otherwise default to injectables due to cost alone.

Comparing Jatenzo to Other TRT Options in West Virginia

The cost of testosterone replacement therapy in West Virginia spans a wide range depending on formulation. Placing Jatenzo's $900 monthly price tag in context helps patients and prescribers make informed decisions.

Injectable testosterone cypionate (generic) costs $30 to $75 per month at most WV pharmacies. It requires intramuscular or subcutaneous injection every 1-2 weeks. It is the most widely covered formulation across both Medicaid and commercial plans. A Cochrane systematic review of testosterone replacement confirmed that injectable testosterone effectively restores eugonadal levels with well-characterized pharmacokinetics.

Topical testosterone gels (generic) run $50 to $150 per month. They require daily application and carry a risk of transference to household contacts, particularly women and children. The FDA's boxed warning on testosterone gels addresses this transference risk.

Jatenzo's oral delivery eliminates injection burden and transference risk. The Swerdloff et al. trial showed that Jatenzo's twice-daily oral dosing produced steady-state testosterone levels with less peak-trough variability than biweekly injections. For patients who cannot tolerate injections and live with partners at risk for testosterone transference, the oral route offers distinct clinical advantages. Whether those advantages justify the price differential is a conversation between patient and prescriber.

Nasal testosterone (Natesto) represents another non-injectable option, priced at $500 to $700 per month, with three-times-daily dosing. Testosterone pellets (Testopel) require in-office insertion every 3-4 months with per-procedure costs of $500 to $1,500 depending on the clinic and number of pellets.

Tips to Lower Your Jatenzo Cost in West Virginia

Practical strategies exist for reducing out-of-pocket spending on Jatenzo in West Virginia. Start with insurance optimization. If your current plan excludes Jatenzo, review alternative plans during open enrollment. Some marketplace plans available through the WV exchange may include Jatenzo on formulary.

Request a formulary exception. If your prescriber documents clinical reasons why injectable and topical testosterone are inappropriate (needle phobia with documented vasovagal episodes, skin conditions precluding gel use, household transference risk), some plans will grant an exception.

Stack the Tolmar savings card with commercial insurance. This combination frequently brings the monthly cost to $0 to $75 for eligible patients. Check with Tolmar for current program terms.

Explore compounded alternatives. If brand-name Jatenzo is financially prohibitive and your prescriber is comfortable managing a compounded formulation, a licensed 503A compounding pharmacy in West Virginia can prepare oral testosterone undecanoate at a fraction of the brand cost.

Consider 90-day fills. Some pharmacies and insurance plans offer lower per-unit pricing when dispensing a 90-day supply. Ask your pharmacist whether a 90-day fill reduces your copay.

Contact Tolmar's patient assistance program. For uninsured patients meeting income eligibility criteria, the manufacturer may provide Jatenzo at reduced cost or free. Eligibility requirements and application processes are available through Tolmar directly.

Men starting Jatenzo in West Virginia should have baseline labs drawn before the first dose and follow-up serum testosterone measured 3 to 5 hours after the morning dose at the 4-to-6-week mark, per the FDA-approved prescribing information.